Spatial analysis of global prevalence of multiple sclerosis suggests need for an updated prevalence scale.
Mult Scler Int 2014;
2014:124578. [PMID:
24693432 PMCID:
PMC3945785 DOI:
10.1155/2014/124578]
[Citation(s) in RCA: 32] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2013] [Revised: 01/12/2014] [Accepted: 01/13/2014] [Indexed: 11/17/2022] Open
Abstract
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system with an unknown aetiology.
MS has a geographic pattern of prevalence with high prevalence rates between 45 degrees and 65 degrees north.
In much of the northern hemisphere, there exists a prevalence gradient, with increasing prevalence from south to north.
While genetics may partially explain the latitudinal gradient, it is not strong enough to exclude exogenous variables. Kurtzke initially came up
with a three-zone scale for low, medium, and high prevalence zones. He defined high as 30 or more per 100,000, medium as
5–29 per 100,000, and low as less than 5 per 100,000. In this study, 131 geographic datasets (geocases) were spatially analyzed to
determine whether the existing global prevalence scale needed to be updated. The mean prevalence rate was 67.83/100,000 with rates ranging
from 350/100,000 to 0/100,000. The results of this study suggest that the commonly referenced scale for global MS prevalence needs to be updated
with added zones to reflect significantly higher prevalence rates in some areas of the world. We suggest a five-zone scale: very high (170–350),
high (70–170), medium (38–70), low (13–38), and very low (0–13).
Collapse